The benefits of establishing an in-depth go-to-market commercialization strategy for a new CGT in the beginning of clinical trials
Ben Beckley, EmerGENE
Advertisement
Articles by Ben Beckley, EmerGENE
Advertisement
Latest Updated Articles
Cell and gene therapy success: Overcoming patient and provider apprehensionPublished: January 27th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Samsung Biologics Enters US Manufacturing Market with $280M GSK Site Acquisition
2
Pharma Pulse: TrumpRx Gains Nine New Pharma Partners; DHL Expands LAX Cold Chain Hub
3
Trade & Channel Strategies 2025: Waiting, Watching, and Reshoring
4
President Trump Announces Nine More TrumpRx Participants
5